For example, a novel immunotherapy strategy for pancreatic cancer based on immunostimulating nanoparticles (immuno-NPs) overcomes the highly immunosuppressive tumor environment by simultaneously activating two pathways of innate immunity—STING and TLR4. Here, STING1 is linked to neoplasm.